About this trial
This study will compare L-citrulline and tamsulosin as medical expulsive therapy for adults with single distal ureteral stones.
Eligible participants with a single distal ureteral stone measuring 5 to 10 mm will be randomly assigned to receive either oral L-citrulline 750 mg twice daily or oral tamsulosin 0.4 mg once daily. Treatment will continue until documented stone passage or completion of 4 weeks of therapy, whichever occurs first.
Participants will be followed weekly for up to 4 weeks. The main outcome is stone expulsion within 4 weeks. The study will also assess time to stone expulsion, pain episodes, analgesic use, need for additional intervention, and adverse events.
Eligibility criteria
Qualifiers
Adults aged 18 to 60 years.
Single distal ureteral stone.
Stone size 5 to 10 mm.
Normal renal function.
Disqualifiers
Fever or active urinary tract infection.
Severe hydronephrosis.
Solitary kidney.
Pregnancy.
Trial design
Treatments tested in this trial
- L-Citrulline
- Tamsulosin